Defibrillators Market Forecast: Anticipating Market Evolution and Emerging Technologies

 

The defibrillators market involves devices that deliver an electric shock to the heart in order to restore normal heart rhythm in patients experiencing cardiac arrest or life-threatening cardiac arrhythmias. Defibrillators can be worn externally or implanted inside the body depending on the severity and frequency of arrhythmias. Advance external and implantable defibrillators provide precise diagnosis and treatment to irregular heartbeats and heart attacks. The global rising prevalence of target disease and growing elderly population are increasing the demand for defibrillators for emergency cardiac care.

The defibrillators market is estimated to be valued at US$ 16,843.5 Mn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030. Key players operating in the defibrillators market are Koninklijke Philips N.V., Metrax GmbH, Medtronic, Mindray Medical International Limited, Boston Scientific Corporation, GE Healthcare, Nihon Kohden, Abbott, BIOTRONIK, Stryker, and LivaNova PLC.

Key Takeaways

Key players operating in the defibrillators market are focusing on new product launches and regulatory approvals to strengthen their market position. For instance, in 2022, Philips received FDA approval for its HeartStart OnSite and HeartStart Home defibrillators.

The rising prevalence of cardiovascular diseases and technological advancements in defibrillation technology are fueling market growth. As per WHO, cardiovascular disease accounts for over 17.9 Mn deaths annually worldwide.

Adoption of wireless monitoring, smartphone connectivity, and cloud-based technologies in defibrillators allows continuous monitoring of high-risk patients and quick emergency response, improving clinical outcomes. Major players are collaborating with digital health companies to develop smart defibrillator solutions.

Market Trends

1. Growing demand for wearable and remote defibrillators: Manufacturers are developing remote monitoring technologies and smart patches for continuous monitoring of high-risk patients and quick emergency response during cardiac arrest.

2. Integration of AI and advanced algorithms: Players are integrating AI, augmented reality, and machine learning algorithms to develop advanced algorithms for more accurate arrhythmia detection and appropriate treatment selection in defibrillators.

Market Opportunities

1. Untapped developing markets: Developing regions like Asia Pacific and Latin America offer lucrative growth opportunities owing to increasing healthcare investments, rising healthcare affordability, and growing incidence of target disease.

2. Favorable reimbursement policies: Many developed countries are implementing national reimbursement programs and policies favoring the adoption of technological advanced defibrillators, driving the demand.

Impact of COVID-19 on Defibrillators Market Growth
The COVID-19 pandemic posed unprecedented challenges to the global defibrillators market. The strict lockdowns and social distancing measures disrupted the supply chains and halted non-essential procurements and installations of defibrillators globally. This led to a decline in market growth in 2020 and 2021. However, as the priority shifted to strengthening healthcare infrastructure, the demand saw an uptick. Procurement of defibrillators was accelerated to equip hospitals, clinics, public places, and ambulances to handle medical emergencies better. Telemedicine also became vital for remote monitoring of cardiac patients.

The post-COVID scenario signifies greater focus on preventive healthcare. Policymakers acknowledge the importance of public access defibrillators in malls, airports, corporates, and densely populated areas. Their increased availability can improve cardiac arrest survival rates. Industry players are proactively enhancing their supply chain resilience through diversified manufacturing facilities and strategic partnerships. They also focus on technologically advanced products with features like remote servicing and software upgrades. Looking ahead, population aging, growing incidence of target conditions, and improving accessibility in rural regions are projected to support the sustained growth of the defibrillators market.

Geographical Regions with High Concentration of Defibrillators Market
North America dominates the defibrillators market in terms of value, accounting for over 40% share. This is attributed to the rising geriatric population, growing prevalence of cardiac conditions, and presence of advanced healthcare infrastructure and reimbursement landscape. Other major markets include Western Europe and Asia Pacific. The Asia Pacific region has emerged as one with the fastest growth, driven by unmet clinical needs, increasing healthcare expenditures, growing medical tourism, and expanding access in middle-income countries like India and China.

Fastest Growing Regional Market for Defibrillators
The Asia Pacific region presents immense opportunities for stakeholders in the defibrillators market. It is expected to grow at the fastest pace during the forecast period from 2023 to 2030. This can be accredited to factors like rising incidence of target diseases, surging disposable incomes, growing medical insurance penetration, improving quality of care, expansion of private healthcare systems, and massive investments by market players. Additionally, supportive initiatives from governments, non-profit organizations, and hospitals associations to place public access defibrillators are aiding the increased adoption in Asian countries.

Defibrillators Market Dynamics: Market Competitiveness Evaluation

 A defibrillator is a device used to deliver an electric shock to the heart in order to restore normal heart rhythm (arrhythmia) when the heart's electrical system malfunctions. It is commonly used after sudden cardiac arrest (SCA) to allow immediate restoration of the normal heart rhythm through cardioversion, defibrillation, and pacing of the heart. The rising incidence of SCA is one of the key factors driving the demand for defibrillators globally. Some other advantages of defibrillators include portability, ease of use, and ability to deliver multiple shocks to restore heart rhythm effectively.They play a crucial role in saving lives by preventing or terminating life-threatening cardiac arrhythmias like ventricular fibrillation.

The Global Defibrillators Market is estimated to be valued at US$ 16,843.5 Mn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the Defibrillators market are Koninklijke Philips N.V., Metrax GmbH, Medtronic, Mindray Medical International Limited, Boston Scientific Corporation, GE Healthcare, Nihon Kohden, Abbott, BIOTRONIK, Stryker, and LivaNova PLC. Koninklijke Philips N.V. held the largest market share in 2021 owing to its diverse product portfolio and strong global presence.

Growing prevalence of cardiovascular diseases and rise in demand for advanced defibrillation devices present significant growth opportunities in the market. The U.S., Japan, China, and India are expected to offer high potential for defibrillator devices amid rise in healthcare expenditure.

Key players are focusing on expanding their footprint in emerging markets through strategic collaborations and new product launches. For instance, in 2022, Abbott launched its strongest and most versatile defibrillator - EnSite X EP System -indicated for cardiac mapping and ablation procedures globally.

Market Drivers
Rising geriatric population susceptible to cardiac conditions- Globally, the geriatric population aged 65 years and above is growing at an impressive rate. As age advances, the risk of cardiac arrhythmias increases significantly. This growing senior demographic presents a strong patient pool driving the defibrillators market.

Improving reimbursement policies- Favorable reimbursements especially in developed nations encourage widespread adoption of expensive defibrillator devices. Public and private insurance coverage for defibrillators boosts their market value.

Market Restrains
High cost of implanted defibrillators- Implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) involve substantial upfront costs, making them inaccessible for many patients. This hinders overall market revenue growth.

Lack of awareness in developing nations- In lower and middle-income countries, there exists a lack of awareness about sudden cardiac arrest and the role of defibrillators in arrest management. This acts as a key restraint.

Segment Analysis
This market is dominated by the automated external defibrillator (AED) segment accounting for over 40% share. AEDs are designed to be used by laypeople without any medical training. They have voice prompts to guide the user through the process of administering electric shocks to heart. These devices are majorly installed in public places like malls, airports, railway stations etc to enable quick response in case of cardiac emergencies. The demand is high in such segments owing to increasing focus on public access defibrillation programs globally.

The implantable cardioverter defibrillator (ICD) segment is the next major segment with around 30% share. ICDs are small devices implanted in the chest or abdomen to monitor the heart rhythm continuously and treat life-threatening cardiac arrhythmias like ventricular tachycardia and ventricular fibrillation with electric shocks. The growth is driven by rising risk of arrhythmias due to ageing population and growing incidence of cardiovascular diseases. Advanced features like cardiac resynchronization therapy in CRT-Ds and subcutaneous ICDs are gaining market acceptance.

Global Analysis
The North America region dominates the global defibrillators market with around 45% share attributed to growing geriatric population, rising awareness about sudden cardiac arrest, and strategic initiatives to install AEDs in public places. Asia Pacific is expected to be the fastest growing region during the forecast period due to rising medical tourism, improving healthcare infrastructure and increasing burden of cardiovascular diseases. Countries like China and India offer immense growth opportunities owing to their large population base experiencing higher vulnerability to cardiac conditions. Regions like Europe and Latin America are also promising markets backed by supportive reimbursement policies and government funding initiatives regarding public defibrillation programs.